Transcriptome profiling of two Moringa species and insights into their antihyperglycemic activity

Please use this identifier to cite or link to this item: http://tdudspace.texicon.in:8080/jspui/handle/123456789/587

Full metadata record

DC Field	Value	Language
dc.contributor.author	Shafi, K. Mohamed	-
dc.contributor.author	Sajeevan, Radha Sivarajan	-
dc.contributor.author	Kouser, Sania	-
dc.contributor.author	Chethala N, Vishnuprasad	-
dc.contributor.author	Ramanathan, Sowdhamini	-
dc.date.accessioned	2025-03-11T11:15:20Z	-
dc.date.available	2025-03-11T11:15:20Z	-
dc.date.issued	2022	-
dc.identifier.uri	http://tdudspace.texicon.in:8080/jspui/handle/123456789/587	-
dc.description.abstract	Moringa concanensis Nimmo (MC), a plant that resembles Moringa oleifera Lam. (MO), has less scientific information but has traditionally been used as a medicinal plant. Moringa species have long been known for their medicinal qualities, which include antioxidant, anti-inflammatory, anticancer, and antihyperglycemic effects. We investigated the antidiabetic potential of MC and MO species in this study by using transcriptome profiling, metabolite analysis, and in vitro assay studies.	en_US
dc.language.iso	en	en_US
dc.publisher	BMC Plant Biology	en_US
dc.subject	Moringaceae	en_US
dc.subject	Diabetes	en_US
dc.subject	RNA-seq	en_US
dc.subject	Transcript expression	en_US
dc.subject	Secondary metabolites	en_US
dc.subject	Enzyme inhibition	en_US
dc.title	Transcriptome profiling of two Moringa species and insights into their antihyperglycemic activity	en_US
dc.type	Article	en_US
Appears in Collections:	Researcher/Student Publications

Files in This Item:

File	Description	Size	Format
Transcriptome profiling of two Moringa species and insights into their antihyperglycemic activity.pdf		524.79 kB	Adobe PDF	View/Open